Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis
Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL
Receptor-Deficient Mice.
Authors
Willecke F, Yuan C, Oka K, Chan L, Hu Y, Barnhart S, Bornfeldt KE, Goldberg IJ,
Fisher EA
Submitted By
Edward Fisher on 7/7/2015
Status
Published
Journal
PLoS ONE
Year
2015
Date Published
Volume : Pages
10 : e0128996
PubMed Reference
26046657
Abstract
We tested whether a high fat diet (HFD) containing the inflammatory dietary
fatty acid palmitate or insulin deficient diabetes altered the remodeling of
atherosclerotic plaques in LDL receptor knockout (Ldlr-/-) mice. Cholesterol
reduction was achieved by using a helper-dependent adenovirus (HDAd) carrying
the gene for the low-density lipoprotein receptor (Ldlr; HDAd-LDLR). After
injection of the HDAd-LDLR, mice consuming either HFD, which led to insulin
resistance but not hyperglycemia, or low fat diet (LFD), showed regression
compared to baseline. However there was no difference between the two groups in
terms of atherosclerotic lesion size, or CD68+ cell and lipid content. Because
of the lack of effects of these two diets, we then tested whether viral-mediated
cholesterol reduction would lead to defective regression in mice with greater
hyperglycemia. In both normoglycemic and streptozotocin (STZ)-treated
hyperglycemic mice, HDAd-LDLR significantly reduced plasma cholesterol levels,
decreased atherosclerotic lesion size, reduced macrophage area and lipid
content, and increased collagen content of plaque in the aortic sinus. However,
reductions in anti-inflammatory and ER stress-related genes were less pronounced
in STZ-diabetic mice compared to non-diabetic mice. In conclusion, HDAd-mediated
Ldlr gene therapy is an effective and simple method to induce atherosclerosis
regression in Ldlr-/- mice in different metabolic states.
Investigators with authorship
Name
Institution
Karin Bornfeldt
University of Washington
Edward Fisher
New York University School of Medicine
Ira Goldberg
New York University School of Medicine
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!